Takeda Pharmaceutical/TAK

$13.38

0.14%
-
1D1W1MYTD1YMAX

About Takeda Pharmaceutical

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.

Ticker

TAK

Sector

Healthcare

Trading on

NYSE

Industry

Biotechnology & Drugs

CEO

Christophe Weber

Employees

49,095

Headquarters

Chuo-ku, Japan

TAK Metrics

BasicAdvanced
$41.64B
Market cap
36.30
P/E ratio
$0.36
EPS
0.59
Beta
-
Dividend rate
7.24%
Dividend yield
$41.64B
0.59136
$17.12
$13.11
1.86M
1.064
0.552
63.689
69.181
161.89%
2.83%
1.29%
2.76%
1.54%
36.304
1.544
0.953
7.24%
5.69%
-35.91%
6.96%
92.64%

What the Analysts think about TAK

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 3 analysts.
36.92% upside
High $19.92
Low $17.13
$13.38
Current price
$18.32
Average price target

TAK Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
9.51% profit margin
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
¥1.11T
6.53%
Net income
¥105.72B
-320.11%
Profit margin
9.51%
-306.74%

TAK Earnings Performance

No data availble
Quarterly data is not available. You can look at the annual data instead.

Earnings per share (EPS)

Company profitability
-
QuarterlyAnnual
Actual
Expected
Surprise
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
ADR

Upcoming events

FAQs

What’s the current market cap for Takeda Pharmaceutical stock?

Takeda Pharmaceutical (TAK) has a market cap of $41.64B as of April 23, 2024.

What is the P/E ratio for Takeda Pharmaceutical stock?

The price to earnings (P/E) ratio for Takeda Pharmaceutical (TAK) stock is 36.3 as of April 23, 2024.

Does Takeda Pharmaceutical stock pay dividends?

No, Takeda Pharmaceutical (TAK) stock does not pay dividends to its shareholders as of April 23, 2024.

When is the next Takeda Pharmaceutical dividend payment date?

Takeda Pharmaceutical (TAK) stock does not pay dividends to its shareholders.

What is the beta indicator for Takeda Pharmaceutical?

Takeda Pharmaceutical (TAK) has a beta rating of 0.59. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Takeda Pharmaceutical stock price target?

The target price for Takeda Pharmaceutical (TAK) stock is $18.32, which is 36.92% above the current price of $13.38. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Takeda Pharmaceutical stock

Buy or sell Takeda Pharmaceutical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing